Advanced searches left 3/3

Acute Lymphoblastic Leukemia - PLOS

Summarized by Plex Scholar
Last Updated: 11 April 2022

* If you want to update the article please login/register

Incidence, severity, and preventability of adverse events during the induction of patients with acute lymphoblastic leukemia in a tertiary care pediatric hospital in Mexico

Pediatric oncology patients have a high prevalence of symptoms due to healthcare-related adverse events. During the induction phase in a tertiary care pediatric hospital in Mexico, this report sought to investigate the prevalence, types, severity, and prevention of adverse events in pediatric patients with acute lymphoblastic leukemia. This review examined a cohort based on medical records from 2015 to 2017. The incidence of adverse events were estimated by type, severity, and preventability. Pediatric patients with acute lymphoblastic leukemia were enrolled in one-hundred and eighty-one pediatric patients with acute lymphoblastic leukemia. During induction, an overall adverse events rate of 51. 8 per 1000 patient-days was estimated, representing 82% of patients. Increasing the safety and quality of the care of children with acute lymphoblastic leukemia is likely, and this can help minimize and avoid adverse events related to morbidity and mortality during the remission induction phase.

Source link: https://doi.org/10.1371/journal.pone.0265450

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions